A pharmacokinetic safety study to compare GTN blood plasma levels of MED2002 with existing cardiovascular GTN drugs

Trial Profile

A pharmacokinetic safety study to compare GTN blood plasma levels of MED2002 with existing cardiovascular GTN drugs

Not stated
Phase of Trial: Phase I

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Nitroglycerin (Primary)
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics
  • Most Recent Events

    • 30 Mar 2017 New trial record
    • 23 Mar 2017 According to a Futura Medical media release, the company is consulting with the UK and US regulatory authorities to finalize design and timing of this study.
    • 23 Mar 2017 According to a Futura Medical media release, the company expects completion of the trial in the fourth quarter of 2018 and regulatory submissions in the second quarter of 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top